# Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL)

> **NCT02830919** · PHASE3 · COMPLETED · sponsor: **Eurofarma Laboratorios S.A.** · enrollment: 627 (actual)

## Conditions studied

- Osteoarthritis of Knee

## Interventions

- **DRUG:** Glucosamine and chondroitin sulfate combination (Eurofarma)
- **DRUG:** Glucosamine and chondroitin sulfate combination (Zodic)

## Key facts

- **NCT ID:** NCT02830919
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-05
- **Primary completion:** 2019-05-10
- **Final completion:** 2019-05-10
- **Target enrollment:** 627 (ACTUAL)
- **Last updated:** 2019-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02830919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02830919, "Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02830919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*